Outcome | Intervention group N = 50 | Control group N = 25 | Model A N = 75 |  |  | Model B N = 70 |  |  |
---|---|---|---|---|---|---|---|---|
Serum concentrations | Mean (sd) | Mean (sd) | B (95% CI) | P value | d | B (95% CI) | P value | d |
IGF-1 | ||||||||
 Baseline | 14.32 (4.04) | 13.82 (4.34) |  |  |  |  |  |  |
 6 months | 15.80 (3.77) | 14.58 (4.10) | 0.42 (− 0.24 to 1.08) | .21 | .10 | 0.41 (− 0.33 to 1.15) | .28 | .10 |
Insulin | ||||||||
 Baseline | 50.37 (36.57) | 56.79 (39.78) |  |  |  |  |  |  |
 6 months | 43.64 (40.51) | 48.10 (21.24) | 0.82 (− 5.15 to 6.79) | .79 | .02 | 2.25 (− 4.39 to 8.88) | .51 | .06 |
Total cholesterol | ||||||||
 Baseline | 5.40 (1.21) | 5.21 (1.17) |  |  |  |  |  |  |
 6 months | 5.51 (1.21) | 5.16 (0.93) | 0.01 (− 0.12 to 0.14) | .91 | .01 | 0.002 (− 0.15 to 0.15) | .98 | .002 |
HDL-cholesterol | ||||||||
 Baseline | 1.42 (0.46) | 1.48 (0.37) |  |  |  |  |  |  |
 6 months | 1.47 (0.47) | 1.51 (0.33) |  − 0.03 (− 0.08 to 0.01) | .14 | .07 |  − 0.03 (− 0.08 to 0.02) | .18 | .07 |
Triglycerides | ||||||||
 Baseline | 1.51 (0.76) | 1.54 (1.14) |  |  |  |  |  |  |
 6 months | 1.57 (0.96) | 1.41 (0.63) | 0.06 (− 0.07 to 0.20) | .37 | .06 | 0.06 (− 0.09 to 0.22) | .42 | .06 |